百利天恒：11月4日召开董事会会议

Group 1 - Baili Tianheng (SH 688506) announced on November 4 that its fifth board meeting was held to discuss the proposal for H-share global offering and listing on the Hong Kong Stock Exchange [1] - For the year 2024, Baili Tianheng's revenue composition is 99.97% from the pharmaceutical manufacturing industry and 0.03% from other businesses [1] - As of the report date, Baili Tianheng's market capitalization is 149.5 billion yuan [1] Group 2 - A significant increase in overseas orders by 246% has been reported in a certain industry, covering over 50 countries and regions [1] - Entrepreneurs have warned about the risk of malicious competition expanding overseas, as some are selling at a loss [1]